All Industries

Top healthtech Companies

659 healthtech companies, sorted by total funding raised.

ErascaIPO

Clinical-stage precision oncology company targeting the RAS/MAPK pathway

San Diego, United States51–200Healthcare, healthtech
Series A·$64.0M·Mar 2019
Akebia TherapeuticsIPO

Fully integrated renal biopharmaceutical company developing medicines for kidney disease patients.

Cambridge, United States201–500healthtech, biotech
Series C·$63.0M·Jun 2013
Nyxoah SAIPO

Medical device company developing the Genio leadless hypoglossal neurostimulation system for obst...

Mont-Saint-Guibert, Belgium51–200healthtech, Healthcare
Series C·$58.8M·Feb 2020
VeracyteIPO

Veracyte is a global cancer diagnostics company that provides genomic tests to help clinicians di...

South San Francisco, United States501–1000Biotech, Diagnostics
Series C·$56.3M·Jun 2013
Cardiff OncologyIPO

Clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies.

San Diego, United States11–50healthtech, Biotech
Growth Equity·$55.0M·Dec 2024
Forte BiosciencesIPO

Clinical-stage biopharmaceutical company developing live biotherapeutics for autoimmune and infla...

Dallas, United States11–50healthtech, Biotech
Corporate Round·$53.0M·Nov 2024
Protalix BioTherapeutics, Inc. (DE)IPO

Biopharmaceutical company developing recombinant therapeutic proteins using proprietary plant cel...

Carmiel, Israel51–200healthtech, biotech
Growth Equity·$52.6M·Mar 2020
Fennec Pharmaceuticals Inc.IPO

Fennec Pharmaceuticals is a commercial-stage specialty pharma company focused on PEDMARK, a thera...

Durham, United States1–10healthtech, Biotech
Corporate Round·$47.9M·Nov 2025
Sonida Senior LivingIPO

Sonida Senior Living operates 95 senior living communities offering independent living, assisted ...

Dallas, United States5001–10000healthtech, Healthcare
Private Equity·$42.5M·Jan 2024
Supernus PharmaceuticalsIPO

Leveraging expertise in product development and oral drug delivery to develop unique specialty ph...

Rockville, United States501–1000CNS, specialty pharma
Venture Unknown·$42.0M·Dec 2011
InogenIPO

Inogen develops and manufactures portable oxygen concentrators for patients requiring supplementa...

Goleta, United States501–1000healthtech, medtech
Series D·$37.0M·Feb 2007
Acumen PharmaceuticalsIPO

Clinical-stage biopharmaceutical company developing targeted therapies for Alzheimer's disease fo...

Charlottesville, United States11–50healthtech, biotech
Private Equity·$35.8M·Mar 2026
PersonalisIPO

Genomic sequencing company enabling precision oncology and cancer biomarker discovery for biophar...

Menlo Park, United States201–500Genomics, Life Sciences
Series C·$33.0M·Jan 2015
Neurocrine BiosciencesIPO

Neurocrine Biosciences is a biopharmaceutical company developing medicines for neurological, endo...

San Diego, United States1001–5000healthtech, Biotech
Venture Unknown·$33.0M·Jan 1994
TalkspaceIPO

The world’s leading online therapy company.

New York, United States201–500Healthcare, Mental Health
Series C·$31.0M·Sep 2017
Fate TherapeuticsIPO

Clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies for aut...

La Jolla, United States51–200Biotech, Life Sciences
Series B·$30.0M·Nov 2009
REGENXBIOIPO

REGENXBIO is a clinical-stage gene therapy company leveraging its NAV Technology Platform to deve...

Rockville, United States201–500healthtech, biotech
Series C·$30.0M
Rocket PharmaceuticalsIPO

Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company focused on advanci...

Cranbury, United StatesBiotech, Healthcare
Series B·$25.4M·Jan 2017
Cardiol Therapeutics Inc.IPO

Late-stage life sciences company focused on advancing the development of anti-inflammatory and an...

Oakville, Canada11–50healthtech, Biotech
Venture Unknown·$24.5M·Jan 2026
AmgenIPO

Develops and manufactures biologic medicines treating serious illnesses and improving patient out...

Thousand Oaks, United States10001+Biotech, Healthcare
Venture Unknown·$19.0M·Apr 1980
SS Innovations International Inc.IPO

Medical technology company developing the SSi Mantra robotic surgical system for minimally invasi...

Gurugram, India51–200healthtech, medtech
Private Equity·$18.6M·Mar 2026
Krystal BiotechIPO

Gene therapy biotechnology company focused on developing and delivering medicines to patients wit...

Pittsburgh, United States201–500healthtech, Biotech
Venture Unknown·$18.0M·Aug 2016
SavaraIPO

A clinical stage biopharmaceutical company focused on rare respiratory diseases.

Austin, United States51–200biotech, pharmaceuticals
Series B·$17.4M·Mar 2013
The Oncology InstituteIPO

Community-based oncology practice delivering evidence-based cancer care including clinical trials...

Downey, United States501–1000healthtech
Private Equity·$16.5M·Jun 2021
Molecular Partners AGIPO

Clinical-stage biotech pioneering DARPin therapeutics for cancer and serious diseases, with a div...

Zurich, Switzerland51–200healthtech, Biotech
Series B·$15.6M·Dec 2009